News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
563,761 Results
Type
Article (39219)
Company Profile (167)
Press Release (524375)
Section
Business (160821)
Career Advice (834)
Deals (26887)
Drug Delivery (77)
Drug Development (70564)
Employer Resources (78)
FDA (15095)
Job Trends (12423)
News (277495)
Policy (25927)
Tag
Academia (2359)
Alliances (44812)
Alzheimer's disease (1137)
Approvals (15069)
Artificial intelligence (223)
Bankruptcy (246)
Best Places to Work (10082)
Biotechnology (122)
Breast cancer (209)
Cancer (1635)
Cardiovascular disease (133)
Career advice (725)
CAR-T (132)
Cell therapy (347)
Clinical research (57718)
Collaboration (665)
Compensation (174)
COVID-19 (2334)
C-suite (154)
Data (1472)
Diabetes (196)
Diagnostics (5905)
Earnings (57198)
Events (79770)
Executive appointments (498)
FDA (15981)
Funding (553)
Gene therapy (235)
GLP-1 (638)
Government (3709)
Healthcare (16083)
Infectious disease (2448)
Inflammatory bowel disease (111)
IPO (11645)
Job creations (2749)
Job search strategy (658)
Layoffs (358)
Legal (5215)
Lung cancer (262)
Lymphoma (110)
Manufacturing (193)
Medical device (13998)
Medtech (14003)
Mergers & acquisitions (15576)
Metabolic disorders (541)
Neuroscience (1539)
NextGen: Class of 2025 (5570)
Non-profit (3457)
Northern California (1649)
Obesity (288)
Opinion (143)
Patents (147)
People (48267)
Phase I (16837)
Phase II (25948)
Phase III (20166)
Pipeline (688)
Postmarket research (1991)
Preclinical (6279)
Radiopharmaceuticals (221)
Rare diseases (293)
Real estate (4795)
Regulatory (18665)
Research institute (2153)
Resumes & cover letters (121)
Southern California (1475)
Startups (3328)
United States (15335)
Vaccines (588)
Weight loss (217)
Date
Today (63)
Last 7 days (617)
Last 30 days (2163)
Last 365 days (28743)
2025 (4418)
2024 (29495)
2023 (33582)
2022 (44147)
2021 (47426)
2020 (46144)
2019 (40329)
2018 (30759)
2017 (28359)
2016 (27034)
2015 (31398)
2014 (23845)
2013 (20258)
2012 (21946)
2011 (22444)
2010 (20824)
Location
Africa (550)
Arizona (161)
Asia (35513)
Australia (6067)
California (3857)
Canada (1497)
China (382)
Colorado (186)
Connecticut (201)
Europe (76926)
Florida (632)
Georgia (154)
Illinois (395)
Indiana (234)
Japan (127)
Maryland (676)
Massachusetts (2713)
Michigan (206)
Minnesota (290)
New Jersey (1183)
New York (1131)
North Carolina (716)
Northern California (1649)
Ohio (154)
Pennsylvania (877)
South America (812)
Southern California (1475)
Texas (586)
Utah (146)
Washington State (390)
563,761 Results for "nobles medical technology ii".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hyperlipoproteinemia Type II Market Expected to Exhibit a CAGR of 6.85% During 2025-2035, Impelled by Increasing Prevalence of Cardiovascular Diseases.
Hyperlipoproteinemia Type II Market Outlook 2025-2035:
February 3, 2025
·
9 min read
SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference
SeaStar Medical Holding Corporation announces that management will present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference on Thursday, April 18 at 9:30 a.m. Eastern time.
April 11, 2024
·
1 min read
Press Releases
IVOS Medical Receives Phase II SBIR Award from the National Institutes of Health for $1.9M
January 22, 2025
·
2 min read
Press Releases
OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis
February 21, 2025
·
3 min read
Press Releases
Subtle Medical Awarded Phase II Funding for SBIR Grant to Expand SubtleSYNTH™ Technology to Brain Imaging
September 5, 2024
·
2 min read
BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024.
June 24, 2024
·
2 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Initiation of ReDS-SAFE HF II Trial for Advancing Heart Failure Management
February 24, 2025
·
3 min read
Press Releases
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
December 31, 2024
·
9 min read
Drug Development
Opinion: AI Is Pushing the I&I Pendulum From Biologics to Small Molecules
Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making small molecules more attractive in the complex inflammatory & immunology disease space.
February 24, 2025
·
6 min read
·
Christian Antoni
1 of 56,377
Next
